Adams, V. (ed.). 2016. Metrics: What counts in global health. Durham: Duke University Press.
Armstrong, D. 2007. Professionalism, indeterminacy and the EBM project. BioSocieties 2: 73–84.
American Statistical Association. 2016. American Statistical Association releases statement on statistical significance and p-values.
Bachmann, M., and G. Jennings. 2011. Therapeutic vaccines for chronic diseases. Philosophical Transactions of the Royal Society B: Biological Sciences 366: 2815–2822.
Bell, K. 2013. Whither tobacco studies? Sociology Compass 7: 34–44.
Bevans, M., C. Hastings, L. Wehrlen, G. Cusack, A.M. Matlock, C. Miller-Davis, et al. 2011. Defining clinical research nursing practice: Results of a role delineation study. Clinical and Translational Science 4: 421–427.
Bolt, T., and F. Huisman. 2015. Evidence-based medicine in crisis? TGE 25: 102–107.
Bonell, C., A. Fletcher, M. Morton, T. Lorenc, and L. Moore. 2012. Realist randomised controlled trials: A new approach to evaluating complex public health interventions. Social Science and Medicine 75: 2299–2306.
Bonell, C., A. Fletcher, M. Morton, T. Lorenc, and L. Moore. 2013. Methods don’t make assumptions, researchers do: A response to Marchal et al. Social Science and Medicine 94: 81–82.
Bothwell, L.E., J.A. Greene, S.H. Podolsky, and D.S. Jones. 2016. Assessing the gold standard - lessons from the history of RCTs. New England Journal of Medicine 374: 2175–2181.
Boulton, M.G., and N. Hopewell. 2017. The workforce delivering translational and applied health research: A cross sectional survey of their characteristics, studies and responsibilities. Collegian 24: 469–477.
Brueton, V.C., J. Tierney, S. Stenning, S. Harding, S. Meredith, I. Nazareth, et al. 2013. Strategies to improve retention in randomised trials. The Cochrane Database of Systematic Reviews 12: 000032.
Cartwright, N. 2007. Are RCTs the gold standard? BioSocieties 2: 11–20.
Castro, K., M. Bevans, C. Miller-Davis, G. Cusack, F. Loscalzo, A.M. Matlock, et al. 2011. Validating the clinical research nursing domain of practice. Oncology Nursing Forum 38: E72–E80.
Cohn, S. 2014. From health behaviours to health practices: An introduction. Sociology of Health & Illness 36: 157–162.
Cornuz, J., S. Zwahlen, W. Jungi, J. Osterwalder, K. Klingler, G. van Melle, et al. 2008. A vaccine against nicotine for smoking cessation. PLoS ONE 3: e2547.
Craig, P., P. Dieppe, S. Macintyre, S. Michie, I. Nazareth, and M. Petticrew. 2008. Developing and evaluating complex interventions: The new Medical Research Council guidance. BMJ 337: a1655.
Deaton, A., and N. Cartwright. 2016. Understanding and Misunderstanding Randomized Controlled Trials (No. w22595). National Bureau of Economic Research.
De Vries, R., and T. Lemmens. 2006. The social and cultural shaping of medical evidence: Case studies from pharmaceutical research and obstetric science. Social Science and Medicine 62: 2694–2706.
Doing, P. 2008. Give me a laboratory and I will raise a discipline: the past, present, and future (politics) of laboratory studies or an accounting error in STS. In The handbook of science and technology studies, ed. E.J. Hackett, O. Amsterdamska, M.E. Lynch, and J. Wajcman, 279–297. Cambridge: MIT.
European Commission. n.d. Responsible research & innovation. Horizon 2020. The EU Framework Programme for Research and Innovation.
Epstein, S. 1995. The construction of lay expertise: AIDS activism and the forging of credibility in the reform of clinical trials. Science, Technology and Human Values 20: 408–437.
Epstein, S. 1996. Impure science: AIDS, activism, and the politics of knowledge. Berkeley: University of California Press.
Epstein, S. 2008. Inclusion: The politics of difference in medical research. Chicago: University of Chicago Press.
Fisher, J.A. 2009. Medical research for hire: The political economy of pharmaceutical clinical trials. New Brunswick: Rutgers University Press.
Fisher, J.A. 2010. Re-inscribing gender in new modes of medical expertise: The investigator–coordinator relationship in the clinical trials industry. Gender, Work & Organization 17: 150–173.
Frohlich, K., E. Mykhalovskiy, B.D. Poland, R. Haines-Saah, and J. Johnson. 2012. Creating the socially marginalised youth smoker: The role of tobacco control. Sociology of Health & Illness 34: 978–993.
Fulurija, A., T. Lutz, K. Sladko, M. Osto, P. Wielinga, M. Bachmann, et al. 2008. Vaccination against GIP for the treatment of obesity. PLoS ONE 3: e3163.
Geraci, A.A., A. Brunt, and C. Marihart. 2014. The work behind weight-loss surgery: A qualitative analysis of food intake after the first two years post-op. ISRN Obesity. https://doi.org/10.1155/2014/427062.
Getz, K.A. 2008. Restoring public confidence in clinical research. The Monitor 22: 59–62.
Goffman, E. 1959. The presentation of self in everyday life. New York: Anchor.
Goodman, S.N. 2016. Aligning statistical and scientific reasoning. Science 352: 1180–1181.
Green, J., and R. Labonté (eds.). 2008. Critical perspectives in public health. London: Routledge.
Greenhalgh, T., J. Howick, and N. Maskrey. 2014. Evidence based medicine: A movement in crisis? BMJ 348: g3725.
Hanson, S., J. Cross, and A. Jones. 2016. Promoting physical activity interventions in communities with poor health and socio-economic profiles: A process evaluation of the implementation of a new walking group scheme. Social Science & Medicine 169:77–85.
Harbers, M.M.E. 2010. Regional differences in smoking behavior in the Netherlands. RIVM: VTV/NKV. Bilthoven.
Hartmann-Boyce, J., K. Cahill, D. Hatsukami, and J. Cornuz. 2012. Nicotine vaccines for smoking cessation. The Cochrane Library 8: CD007072.
Hawe, P. 2015. Lessons from complex interventions to improve health. Annual Review of Public Health 36: 307–323.
Helgesson, C.-F. 2010. From dirty data to credible scientific evidence: Some practices used to clean data in large randomised clinical trials. In Medical proofs, social experiments: clinical trials in shifting contexts, ed. C. Will and T. Moreira, 49–66. Farnham: Ashgate.
Hoogsteder, P., D. Kotz, P. van Spiegel, W. Viechtbauer, and O. van Schayck. 2014. Efficacy of the nicotine vaccine 3′-AmNic-rEPA (NicVAX) co-administered with varenicline and counselling for smoking cessation. Addiction 109: 1252–1259.
Horstman, K., and R. Houtepen. 2005. [Struggling with healthy living] Worstelen met gezond leven. Amsterdam: Ethiek in de preventie van hart- en vaatziekten.
ICMJE. 2016. Defining the role of authors and contributors. n.p.: International Committee of Medical Journal Editors.
Ioannidis, J.P.A. 2016. Evidence-based medicine has been hijacked: A report to David Sackett. Journal of Clinical Epidemiology 73: 82–86.
Irani, L. 2015a. The cultural work of microwork. New Media & Society 17 (5): 720–739.
Irani, L. 2015b. Difference and dependence among digital workers: The case of Amazon Mechanical Turk. South Atlantic Quarterly 114 (1): 225–234.
Irani, L., and M. Sengul-Jones. 2015. Difference work: A conversation with Lilly Irani. Catalyst:Feminism, Theory, Technoscience 1 (1): 1–14.
Jamal, F., A. Fletcher, N. Shackleton, D. Elbourne, R. Viner, and C. Bonell. 2015. The three stages of building and testing mid-level theories in a realist RCT: A theoretical and methodological case-example. Trials 16: 1–10.
Jespersen, A.P., J. Bønnelycke, and H.H. Eriksen. 2014. Careful science? Bodywork and care practices in randomised clinical trials. Sociology of Health & Illness 36: 655–669.
Kelly, M.P., I. Heath, J. Howick, and T. Greenhalgh. 2015. The importance of values in evidence-based medicine. BMC Medical Ethics 16: 1–8.
Knorr-Cetina, K. 1981. The manufacture of knowledge: An essay on the constructivist and contextual nature of science. Oxford/New York: Pergamon Press.
Knorr-Cetina, K. 1999. Epistemic cultures: How the sciences make knowledge. Cambridge: Harvard University Press.
Latour, B. 1993. We have never been modern. Cambridge: Harvard University Press.
Latour, B., and S. Woolgar. 1986. Laboratory life: The construction of scientific facts. Princeton: Princeton University Press.
Lawton, J., N. Jenkins, J. Darbyshire, R. Holman, A. Farmer, and N. Hallowell. 2011. Challenges of maintaining research protocol fidelity in a clinical care setting: A qualitative study of the experiences and views of patients and staff participating in a randomized controlled trial. Trials 12: 108.
Leigh Star, S. 1991. Invisible work and silenced dialogues in knowledge representation. In Women, work and computerization, ed. I. Eriksson, B. Kitchenham, and K. Tijdens, 81–92. Amsterdam: North-Holland.
Lemmens, T. 2013. Pharmaceutical knowledge governance: A human rights perspective. Journal of Law Medicine & Ethics 41: 163–184.
Luff, P., J. Hindmarsh, and C. Heath (eds.). 2000. Workplace studies: Recovering work practice and informing system design. Cambridge: Cambridge University Press.
Mair, M., and C. Kierans. 2007. Critical reflections on the field of tobacco research: The role of tobacco control in defining the tobacco research agenda. Critical Public Health 17: 103–112.
Marchal, B., G. Westhorp, G. Wong, S. Van Belle, T. Greenhalgh, G. Kegels, et al. 2013. Realist RCTs of complex interventions – an oxymoron. Social Science and Medicine 94: 124–128.
Masterson-Algar, P., C.R. Burton, M.C. Brady, A. Nicoll, C.E. Clarke, C. Rick, et al. 2017. The PD COMM trial: A protocol for the process evaluation of a randomised trial assessing the effectiveness of two types of SLT for people with Parkinson’s disease. Trials 18: 397.
Metzl, J., and A. Kirkland. 2010. Against health. New York: New York UP.
Miller, C.L., K. Mott, M. Cousins, S. Miller, A. Johnson, T. Lawson, et al. 2017. Integrating consumer engagement in health and medical research—An Australian framework. Health Research Policy and Systems 15: 9.
Mol, A. 2013. Mind your plate! The ontonorms of Dutch dieting. Social Studies of Science 43: 379–396.
Moore, G.F., S. Audrey, M. Barker, L. Bond, C. Bonell, W. Hardeman, et al. 2015. Process evaluation of complex interventions: Medical Research Council guidance. BMJ 350: h1258.
MRC. 2000. A framework for the development and evaluation of RCTs for complex interventions to improve health. London: MRC.
Mueller, M.-R. 2004. Involvement and (potential) influence of care providers in the enlistment phase of the informed consent process: the case of aids clinical trials. Nursing Ethics 11: 42–52.
Mueller, M.-R. 2006. The work and occupational trajectories of clinical trials research. Journal of Applied Social Science 23: 44–52.
Nabi. 2011. Nabi biopharmaceuticals announces results of first NicVAX(R) phase III clinical trial. El Segundo: Nasdaq GlobeNewswire.
Nabi/MUMC + . (2009). Protocol Nabi-4508 Phase 2B NicVAX study. Rockville/Maastricht.
Nabi/MUMC + . (n.d.-a). Job vacancy NicVAX research assistants. Maastricht: MUMC + .
Nabi/MUMC + . (n.d.-b). NicVAX study. Form Counselling 2 (phone).
Nachtigal, A., and C.A. Kidron. 2015. Existential multiplicity and the late-modern smoker: Negotiating multiple identities in a support group for smoking cessation. Sociology of Health & Illness 37 (3): 452–467.
Nature. 2016. Randomized controlled trials. Nature.com.
NWO. 2017. Programme responsible innovation. Netherlands Organisation for Scientific Research NWO.
Oakley, A., V. Strange, C. Bonell, E. Allen, and J. Stephenson. 2006. Process evaluation in randomised controlled trials of complex interventions. BMJ 332: 413–416.
Okwaro, F.M., C.I.R. Chandler, E. Hutchinson, C. Nabirye, L. Taaka, M. Kayendeke, et al. 2015. Challenging logics of complex intervention trials: Community perspectives of a health care improvement intervention in rural Uganda. Social Science and Medicine 131: 10–17.
Ophir, A., and S. Shapin. 1991. The place of knowledge. A methodological survey. Science in Context 4: 3–22.
Oudshoorn, N. 2008. Diagnosis at a distance: The invisible work of patients and healthcare professionals in cardiac telemonitoring technology. Sociology of Health & Illness 30: 272–288.
Reynolds, J., D. DiLiberto, L. Mangham-Jefferies, E.K. Ansah, S. Lal, H. Mbakilwa, et al. 2014. The practice of ‘doing’ evaluation: Lessons learned from nine complex intervention trials in action. Implementation Science 9: 75.
Rip, A. 2016. The clothes of the emperor. An essay on RRI in and around Brussels. Journal of Responsible Innovation 3: 290–304.
Rushforth, A. 2015. Meeting pragmatism halfway: Making a pragmatic clinical trial protocol. Sociology of Health & Illness 37: 1285–1298.
Savransky, M., and M. Rosengarten. 2016. What is nature capable of? Evidence, ontology and speculative medical humanities. Medical Humanities 42: 166–172.
Seale, C. 2004. Researching society and culture. London: Sage.
Shapin, S. 1989. The invisible technician. American Scientist 77 (6): 554–563.
Shapin, S., S. Schaffer, and T. Hobbes. 1985. Leviathan and the air-pump. Princeton: Princeton University Press.
Smith, K.E. 2013. Beyond evidence-based policy in public health: The interplay of ideas. Basingstoke: Palgrave.
Squires, A. 2009. Methodological challenges in cross-language qualitative research: A research review. International Journal of Nursing Studies 46: 277–287.
Stanley, J.P. 1978. Forced inference: Uses and abuses of the passive. Paper in Linguistics 10: 299–311.
Star, S.L. 1995. Ecologies of knowledge: Work and politics in science and technology. Albany: State University of New York Press.
Star, S.L., and A. Strauss. 1999. Layers of silence, arenas of voice: The ecology of visible and invisible work. Computer Supported Cooperative Work (CSCW) 8 (1–2): 9–30.
Stilgoe, J., R. Owen, and P. Macnaghten. 2013. Developing a framework for responsible innovation. Research Policy 42: 1568–1580.
Suchman, L. 2000. Making a case: ‘Knowledge’ and ‘routine’ work in document production. In Workplace studies, ed. P. Luff, J. Hindmarch, and C. Heath, 29–45. Cambridge: CUP.
Taebi, B., A. Correljé, E. Cuppen, M. Dignum, and U. Pesch. 2014. Responsible innovation as an endorsement of public values: The need for interdisciplinary research. Journal of Responsible Innovation 1: 118–124.
Timmermans, S. 2011. The joy of science: Finding success in a ‘failed’ randomized clinical trial. Science, Technology and Human Values 36: 549–572.
Timmermans, S., and M. Berg. 1997. Standardization in action: Achieving local universality through medical protocols. Social Studies of Science 27: 273–305.
Tointon, A. 2016. The Pulse on Patient Recruitment. The issue of patient retention in clinical trials. Boston: CenterWatch.
Tonstad, S., E. Heggen, H. Giljam, P.-Å. Lagerbäck, P. Tønnesen, L.D. Wikingsson, et al. 2013. Niccine®, a nicotine vaccine, for relapse prevention. Nicotine & Tobacco Research 15: 1492–1501.
van Schayck, C.P. 2006. Grant application: A new vaccine for the treatment and prevention of nicotine addiction. Efficacy, mechanism and ethical implications. Netherlands: ZonMw, the Netherlands Organisation for Health Research and Development.
Viney, W., F. Callard, and A. Woods. 2015. Critical medical humanities: Embracing entanglement, taking risks. Medical Humanities 41: 2–7.
Vocci, F., and C. Chiang. 2001. Vaccines against nicotine. CNS Drugs 15: 505–514.
Visser, S.S., I. Hutter, and H. Haisma. 2016. Building a framework for theory-based ethnographies for studying intergenerational family food practices. Appetite 97: 49–57.
Vogel, E., and A. Mol. 2014. Enjoy your food: On losing weight and taking pleasure. Sociology of Health & Illness 36: 305–317.
von Schomberg, R. 2013. A vision of responsible research and innovation. In Responsible innovation, ed. R. Owen, J. Bessant, and M. Heintz, 51–74. London: Wiley.
Wahlberg, A., and L. McGoey. 2007. An elusive evidence base: The construction and governance of randomized controlled trials. Biosocieties (special issue on RCTs) 2: 1–10.
Wajcman, J. 1995. Feminist theories of technology. In Handbook of science and technology studies, ed. S. Jasanoff, G.E. Markle, J.C. Petersen, and T.J. Pinch, 189–204. Thousand Oaks: SAGE.
Wajcman, J. 2010. Feminist theories of technology. Cambridge Journal of Economics 34 (1): 143–152.
Weaver, R.R., M. Lemonde, N. Payman, and W.M. Goodman. 2014. Health capabilities and diabetes self-management: The impact of economic, social, and cultural resources. Social Science and Medicine 102: 58–68.
Webster, A., C. Haddad, and C. Waldby. 2011. Experimental heterogeneity and standardisation: Stem cell products and the clinical trial process. Biosocieties 6: 401–419.
Wilkes, L., D. Jackson, C. Miranda, and R. Watson. 2012. The role of clinical trial nurses: An Australian perspective. Collegian 19: 239–246.
Will, C. 2007. The alchemy of clinical trials. Biosocieties 2: 85–99.
Will, C., and T. Moreira (eds.). 2010. Medical proofs, social experiments: Clinical trials in shifting contexts. Farnham: Ashgate.
Will, C., and K. Weiner. 2014. Sustained multiplicity in everyday cholesterol reduction: Repertoires and practices in talk about ‘healthy living’. Sociology of Health & Illness 36: 291–304.
ZonMW. n.d. Project: A new vaccine for the treatment and prevention of nicotine addiction. zonmw.nl.